|
|
DF/HCC News
Cancer Cell Biology Program: Matchmaker to Interdisciplinary Researchers Conquering cancer is too daunting for any one discipline, approach, or individual
Translating disease-related findings While John Blenis, PhD (HMS), a cell biologist and biochemist interested in cancer cell metabolism, works at the basic science level, he collaborates with pre-clinical researchers
Cell Manipulation Core Facility The Cell Manipulation Core Facility (CMCF) produces safe and effective cellular components for subjects enrolled in novel therapeutic clinical research protocols
Eleven new members join DF/HCC Eleven individuals have recently joined DF/HCC
DF/HCC-led trials aim to overcome resistance in metastatic GIST Gastrointestinal stromal tumor (GIST) is the most common sarcoma of the gastrointestinal tract
Cells to Society: New centers explore two major areas of cancer disparities The earlier onset, higher rates, and worse outcomes of cancer in poor and minority populations in the United States may be well documented, but they are not well understood
Major study tests primary prevention power of vitamin D and omega-3s Television news and cereal boxes tout the health benefits of extra vitamin D and omega-3 fatty acids, but exceeding the recommended dietary allowance of either is not a proven way to prevent cancer nor cardiovascular di
Displaying results 1 to 7 out of 158
|
